Skip to main
TDOC

Teladoc (TDOC) Stock Forecast & Price Target

Teladoc (TDOC) Analyst Ratings

Based on 16 analyst ratings
Hold
Strong Buy 13%
Buy 13%
Hold 75%
Sell 0%
Strong Sell 0%

Bulls say

Teladoc Health is well-positioned in the growing virtual healthcare industry and has displayed strong financial performance with steady revenue and EBITDA growth. The company's expansion into the insurance market, as well as international markets, is expected to drive further growth. However, there is some uncertainty surrounding the BetterHelp segment's growth potential and competition in the market, which could impact the company's financials in the near term. Overall, Teladoc Health's market leadership and continued investments in its platform make it a strong long-term investment opportunity.

Bears say

Teladoc Health is facing challenges as it transitions from rapid growth to steady and more profitable growth. While their virtual care platform and expanding mental health, chronic care, and primary care services provide growth opportunities, achieving success requires continued efforts to lead the healthcare industry towards greater adoption of virtual care. Additionally, the success of their Primary 360 service, which addresses the lack of standing primary care relationships, could potentially bring in significant revenue. However, there is still uncertainty surrounding the company's ability to generate meaningful upside catalysts and make their ad spend more efficient.

Teladoc (TDOC) has been analyzed by 16 analysts, with a consensus rating of Hold. 13% of analysts recommend a Strong Buy, 13% recommend Buy, 75% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Teladoc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Teladoc (TDOC) Forecast

Analysts have given Teladoc (TDOC) a Hold based on their latest research and market trends.

According to 16 analysts, Teladoc (TDOC) has a Hold consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $7.41, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $7.41, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Teladoc (TDOC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.